UGE Fundamental Analysis - UGE INTERNATIONAL LTD

Fundamental Rating

UGE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 7 industry peers in the Construction & Engineering industry. UGE may be in some trouble as it scores bad on both profitability and health. UGE is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

UGE had negative earnings in the past year.

In the past year UGE has reported a negative cash flow from operations.

In the past 5 years UGE always reported negative net income.

UGE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -19.79%, UGE is doing worse than 75.00% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-19.79%
ROE	N/A
ROIC	N/A

ROA(3y)-19.44%

ROA(5y)-29.86%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

UGE's Gross Margin of 56.24% is amongst the best of the industry. UGE outperforms 87.50% of its industry peers.

In the last couple of years the Gross Margin of UGE has grown nicely.

The Profit Margin and Operating Margin are not available for UGE so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	56.24%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y15.94%

GM growth 5Y42.45%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

UGE does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, UGE has more shares outstanding

Compared to 5 years ago, UGE has more shares outstanding

Compared to 1 year ago, UGE has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -1.55, we must say that UGE is in the distress zone and has some risk of bankruptcy.

UGE has a Altman-Z score of -1.55. This is in the lower half of the industry: UGE underperforms 75.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-1.55

ROIC/WACCN/A

WACC6.37%

2.3 Liquidity

UGE has a Current Ratio of 0.25. This is a bad value and indicates that UGE is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.25, UGE is doing worse than 75.00% of the companies in the same industry.

A Quick Ratio of 0.25 indicates that UGE may have some problems paying its short term obligations.

The Quick ratio of UGE (0.25) is worse than 75.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.25
Quick Ratio	0.25

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for UGE have decreased strongly by -70.37% in the last year.

UGE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -71.01%.

Measured over the past years, UGE shows a very negative growth in Revenue. The Revenue has been decreasing by -41.18% on average per year.

EPS 1Y (TTM)-70.37%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-33.33%

Revenue 1Y (TTM)-71.01%

Revenue growth 3Y-5.62%

Revenue growth 5Y-41.18%

Sales Q2Q%-10.3%

3.2 Future

The Earnings Per Share is expected to grow by 31.23% on average over the next years. This is a very strong growth

Based on estimates for the next years, UGE will show a very strong growth in Revenue. The Revenue will grow by 157.73% on average per year.

EPS Next Y-12.58%

EPS Next 2Y-2.08%

EPS Next 3Y20.75%

EPS Next 5Y31.23%

Revenue Next Year64.19%

Revenue Next 2Y138.13%

Revenue Next 3Y150.23%

Revenue Next 5Y157.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UGE. In the last year negative earnings were reported.

Also next year UGE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as UGE's earnings are expected to grow with 20.75% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-2.08%

EPS Next 3Y20.75%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for UGE!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

UGE INTERNATIONAL LTD

TSX-V:UGE (8/15/2024, 7:00:00 PM)

+0.01 (+0.5%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryConstruction & Engineering

Earnings (Last)08-14 2024-08-14

Earnings (Next)11-27 2024-11-27

Inst Owners0.17%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap0

Revenue(TTM)1.16M

Net Income(TTM)-14.06M

Analysts42.22

Price Target2.04 (2%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-22.47%

Min EPS beat(2)-37.06%

Max EPS beat(2)-7.87%

EPS beat(4)0

Avg EPS beat(4)-100.76%

Min EPS beat(4)-323.65%

Max EPS beat(4)-7.87%

EPS beat(8)2

Avg EPS beat(8)-58.63%

EPS beat(12)2

Avg EPS beat(12)-63.24%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-49.43%

Min Revenue beat(2)-54.21%

Max Revenue beat(2)-44.66%

Revenue beat(4)0

Avg Revenue beat(4)-45.95%

Min Revenue beat(4)-55.89%

Max Revenue beat(4)-29.06%

Revenue beat(8)1

Avg Revenue beat(8)-16.05%

Revenue beat(12)2

Avg Revenue beat(12)-7.17%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)9.09%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0.7%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-43.83%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	41.59
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.63

EYN/A

EPS(NY)-0.61

Fwd EYN/A

FCF(TTM)-1.32

FCFYN/A

OCF(TTM)-0.71

OCFYN/A

SpS0.05

BVpS-0.8

TBVpS-0.84

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-19.79%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	56.24%
FCFM	N/A

ROA(3y)-19.44%

ROA(5y)-29.86%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y15.94%

GM growth 5Y42.45%

F-Score1

Asset Turnover0.02

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	4483.66%
Cap/Sales	1268.91%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.25
Quick Ratio	0.25
Altman-Z	-1.55

F-Score1

WACC6.37%

ROIC/WACCN/A

Cap/Depr(3y)3619.14%

Cap/Depr(5y)2980.59%

Cap/Sales(3y)484.64%

Cap/Sales(5y)316.8%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-70.37%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-33.33%

EPS Next Y-12.58%

EPS Next 2Y-2.08%

EPS Next 3Y20.75%

EPS Next 5Y31.23%

Revenue 1Y (TTM)-71.01%

Revenue growth 3Y-5.62%

Revenue growth 5Y-41.18%

Sales Q2Q%-10.3%

Revenue Next Year64.19%

Revenue Next 2Y138.13%

Revenue Next 3Y150.23%

Revenue Next 5Y157.73%

EBIT growth 1Y-93.7%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year19.64%

EBIT Next 3Y40.19%

EBIT Next 5Y65.4%

FCF growth 1Y-205.71%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-174.11%

OCF growth 3YN/A

OCF growth 5YN/A

UGE INTERNATIONAL LTD / UGE.CA FAQ

What is the fundamental rating for UGE stock?

ChartMill assigns a fundamental rating of 1 / 10 to UGE.CA.

Can you provide the valuation status for UGE INTERNATIONAL LTD?

ChartMill assigns a valuation rating of 1 / 10 to UGE INTERNATIONAL LTD (UGE.CA). This can be considered as Overvalued.

What is the profitability of UGE stock?

UGE INTERNATIONAL LTD (UGE.CA) has a profitability rating of 1 / 10.

Can you provide the expected EPS growth for UGE stock?

The Earnings per Share (EPS) of UGE INTERNATIONAL LTD (UGE.CA) is expected to decline by -12.58% in the next year.

UGE INTERNATIONAL LTD (UGE.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

UGE INTERNATIONAL LTD / UGE.CA FAQ

What is the fundamental rating for UGE stock?

Can you provide the valuation status for UGE INTERNATIONAL LTD?

What is the profitability of UGE stock?

Can you provide the expected EPS growth for UGE stock?